NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy.

Mirella El Khoury,Olivier Biondi,Gaelle Bruneteau,Delphine Sapaly,Sabrina Bendris,Cynthia Bezier,Zoé Clerc, Elias Abi Akar,Laure Weill,Assaad A Eid,Frédéric Charbonnier

Frontiers in cellular neuroscience（2023）

引用 0|浏览6

暂无评分

摘要

The pharmacological inhibition of NOX4 by GKT137831/Setanaxib is neuroprotector and could represent a complementary therapeutic strategy to fight against SMA.

查看译文

关键词

oxidase,complementary therapeutic strategy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要